Industry Research Reports
Home > Reports > Chemical & Material > Global Reagent Grade Firocoxib Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Reagent Grade Firocoxib Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-21
Pages: 159 Pages
Report ld: 5193486
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Reagent Grade Firocoxib market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
From a downstream perspective, Veterinary accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Reagent Grade Firocoxib leading manufacturers including BOC Sciences, TargetMol, Merck KgaA, Santa Cruz Biotechnology, Toronto Research Chemicals, Ambinter, Carbosynth, Henan Tianfu Chemical, J&K Scientific, Chemsky International, etc., dominate supply; the top five capture approximately % of global revenue, with BOC Sciences leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Reagent Grade Firocoxib market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- BOC Sciences
- TargetMol
- Merck KgaA
- Santa Cruz Biotechnology
- Toronto Research Chemicals
- Ambinter
- Carbosynth
- Henan Tianfu Chemical
- J&K Scientific
- Chemsky International
- Chemwill Asia
- ChemeGen
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Primary Reagent
- Spectrum-Pure Reagent
- High-Purity Reagent
Segment by Application
- Veterinary
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Reagent Grade Firocoxib study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Reagent Grade Firocoxib: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Reagent Grade Firocoxib Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Primary Reagent
1.2.3 Spectrum-Pure Reagent
1.2.4 High-Purity Reagent
1.3 Market Segmentation by Application
1.3.1 Global Reagent Grade Firocoxib Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Veterinary
1.3.3 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Reagent Grade Firocoxib Revenue Estimates and Forecasts 2020-2031
2.2 Global Reagent Grade Firocoxib Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Reagent Grade Firocoxib Sales Estimates and Forecasts 2020-2031
2.4 Global Reagent Grade Firocoxib Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Reagent Grade Firocoxib Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Reagent Grade Firocoxib Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Reagent Grade Firocoxib Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Primary Reagent Market Size by Manufacturers
4.5.2 Spectrum-Pure Reagent Market Size by Manufacturers
4.5.3 High-Purity Reagent Market Size by Manufacturers
4.6 Global Reagent Grade Firocoxib Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Reagent Grade Firocoxib Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Reagent Grade Firocoxib Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Reagent Grade Firocoxib Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Reagent Grade Firocoxib Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Reagent Grade Firocoxib Sales and Revenue by Type (2020-2031)
7.4 North America Reagent Grade Firocoxib Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Reagent Grade Firocoxib Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Reagent Grade Firocoxib Sales and Revenue by Type (2020-2031)
8.4 Europe Reagent Grade Firocoxib Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Reagent Grade Firocoxib Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Reagent Grade Firocoxib Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Reagent Grade Firocoxib Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Reagent Grade Firocoxib Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Reagent Grade Firocoxib Sales and Revenue by Type (2020-2031)
10.4 Central and South America Reagent Grade Firocoxib Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Reagent Grade Firocoxib Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Reagent Grade Firocoxib Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Reagent Grade Firocoxib Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Reagent Grade Firocoxib Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 BOC Sciences
12.1.1 BOC Sciences Corporation Information
12.1.2 BOC Sciences Business Overview
12.1.3 BOC Sciences Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.1.4 BOC Sciences Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 BOC Sciences Reagent Grade Firocoxib Sales by Product in 2024
12.1.6 BOC Sciences Reagent Grade Firocoxib Sales by Application in 2024
12.1.7 BOC Sciences Reagent Grade Firocoxib Sales by Geographic Area in 2024
12.1.8 BOC Sciences Reagent Grade Firocoxib SWOT Analysis
12.1.9 BOC Sciences Recent Developments
12.2 TargetMol
12.2.1 TargetMol Corporation Information
12.2.2 TargetMol Business Overview
12.2.3 TargetMol Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.2.4 TargetMol Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 TargetMol Reagent Grade Firocoxib Sales by Product in 2024
12.2.6 TargetMol Reagent Grade Firocoxib Sales by Application in 2024
12.2.7 TargetMol Reagent Grade Firocoxib Sales by Geographic Area in 2024
12.2.8 TargetMol Reagent Grade Firocoxib SWOT Analysis
12.2.9 TargetMol Recent Developments
12.3 Merck KgaA
12.3.1 Merck KgaA Corporation Information
12.3.2 Merck KgaA Business Overview
12.3.3 Merck KgaA Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.3.4 Merck KgaA Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Merck KgaA Reagent Grade Firocoxib Sales by Product in 2024
12.3.6 Merck KgaA Reagent Grade Firocoxib Sales by Application in 2024
12.3.7 Merck KgaA Reagent Grade Firocoxib Sales by Geographic Area in 2024
12.3.8 Merck KgaA Reagent Grade Firocoxib SWOT Analysis
12.3.9 Merck KgaA Recent Developments
12.4 Santa Cruz Biotechnology
12.4.1 Santa Cruz Biotechnology Corporation Information
12.4.2 Santa Cruz Biotechnology Business Overview
12.4.3 Santa Cruz Biotechnology Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.4.4 Santa Cruz Biotechnology Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Santa Cruz Biotechnology Reagent Grade Firocoxib Sales by Product in 2024
12.4.6 Santa Cruz Biotechnology Reagent Grade Firocoxib Sales by Application in 2024
12.4.7 Santa Cruz Biotechnology Reagent Grade Firocoxib Sales by Geographic Area in 2024
12.4.8 Santa Cruz Biotechnology Reagent Grade Firocoxib SWOT Analysis
12.4.9 Santa Cruz Biotechnology Recent Developments
12.5 Toronto Research Chemicals
12.5.1 Toronto Research Chemicals Corporation Information
12.5.2 Toronto Research Chemicals Business Overview
12.5.3 Toronto Research Chemicals Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.5.4 Toronto Research Chemicals Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Toronto Research Chemicals Reagent Grade Firocoxib Sales by Product in 2024
12.5.6 Toronto Research Chemicals Reagent Grade Firocoxib Sales by Application in 2024
12.5.7 Toronto Research Chemicals Reagent Grade Firocoxib Sales by Geographic Area in 2024
12.5.8 Toronto Research Chemicals Reagent Grade Firocoxib SWOT Analysis
12.5.9 Toronto Research Chemicals Recent Developments
12.6 Ambinter
12.6.1 Ambinter Corporation Information
12.6.2 Ambinter Business Overview
12.6.3 Ambinter Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.6.4 Ambinter Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Ambinter Recent Developments
12.7 Carbosynth
12.7.1 Carbosynth Corporation Information
12.7.2 Carbosynth Business Overview
12.7.3 Carbosynth Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.7.4 Carbosynth Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Carbosynth Recent Developments
12.8 Henan Tianfu Chemical
12.8.1 Henan Tianfu Chemical Corporation Information
12.8.2 Henan Tianfu Chemical Business Overview
12.8.3 Henan Tianfu Chemical Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.8.4 Henan Tianfu Chemical Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Henan Tianfu Chemical Recent Developments
12.9 J&K Scientific
12.9.1 J&K Scientific Corporation Information
12.9.2 J&K Scientific Business Overview
12.9.3 J&K Scientific Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.9.4 J&K Scientific Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 J&K Scientific Recent Developments
12.10 Chemsky International
12.10.1 Chemsky International Corporation Information
12.10.2 Chemsky International Business Overview
12.10.3 Chemsky International Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.10.4 Chemsky International Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Chemsky International Recent Developments
12.11 Chemwill Asia
12.11.1 Chemwill Asia Corporation Information
12.11.2 Chemwill Asia Business Overview
12.11.3 Chemwill Asia Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.11.4 Chemwill Asia Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Chemwill Asia Recent Developments
12.12 ChemeGen
12.12.1 ChemeGen Corporation Information
12.12.2 ChemeGen Business Overview
12.12.3 ChemeGen Reagent Grade Firocoxib Product Models, Descriptions and Specifications
12.12.4 ChemeGen Reagent Grade Firocoxib Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 ChemeGen Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Reagent Grade Firocoxib Industry Chain
13.2 Reagent Grade Firocoxib Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Reagent Grade Firocoxib Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Reagent Grade Firocoxib Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Reagent Grade Firocoxib Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Reagent Grade Firocoxib Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Reagent Grade Firocoxib Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Reagent Grade Firocoxib Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Reagent Grade Firocoxib Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Reagent Grade Firocoxib Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Reagent Grade Firocoxib Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Reagent Grade Firocoxib Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 7. Global Reagent Grade Firocoxib Sales by Region (2020-2025) & (Kg)
Table 8. Global Reagent Grade Firocoxib Sales by Region (2026-2031) & (Kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Reagent Grade Firocoxib Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 11. Global Reagent Grade Firocoxib Production by Region (2020-2025) & (Kg)
Table 12. Global Reagent Grade Firocoxib Production by Region (2026-2031) & (Kg)
Table 13. Global Reagent Grade Firocoxib Sales by Manufacturers (2020-2025) & (Kg)
Table 14. Global Reagent Grade Firocoxib Sales Share by Manufacturers (2020-2025)
Table 15. Global Reagent Grade Firocoxib Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Reagent Grade Firocoxib Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Reagent Grade Firocoxib by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reagent Grade Firocoxib as of 2024)
Table 19. Global Reagent Grade Firocoxib Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Reagent Grade Firocoxib Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)
Table 21. Key Manufacturers Reagent Grade Firocoxib Manufacturing Base and Headquarters
Table 22. Global Reagent Grade Firocoxib Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Reagent Grade Firocoxib Sales by Type (2020-2025) & (Kg)
Table 26. Global Reagent Grade Firocoxib Sales by Type (2026-2031) & (Kg)
Table 27. Global Reagent Grade Firocoxib Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Reagent Grade Firocoxib Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Reagent Grade Firocoxib ASP by Type (2020-2031) & (US$/Kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Reagent Grade Firocoxib Sales by Application (2020-2025) & (Kg)
Table 32. Global Reagent Grade Firocoxib Sales by Application (2026-2031) & (Kg)
Table 33. Reagent Grade Firocoxib High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Reagent Grade Firocoxib Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Reagent Grade Firocoxib Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Reagent Grade Firocoxib ASP by Application (2020-2031) & (US$/Kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Reagent Grade Firocoxib Growth Accelerators and Market Barriers
Table 40. North America Reagent Grade Firocoxib Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Reagent Grade Firocoxib Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Reagent Grade Firocoxib Growth Accelerators and Market Barriers
Table 43. Europe Reagent Grade Firocoxib Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Reagent Grade Firocoxib Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Reagent Grade Firocoxib Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Reagent Grade Firocoxib Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Reagent Grade Firocoxib Growth Accelerators and Market Barriers
Table 48. Southeast Asia Reagent Grade Firocoxib Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Reagent Grade Firocoxib Investment Opportunities and Key Challenges
Table 50. Central and South America Reagent Grade Firocoxib Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Reagent Grade Firocoxib Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Reagent Grade Firocoxib Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. BOC Sciences Corporation Information
Table 54. BOC Sciences Description and Major Businesses
Table 55. BOC Sciences Product Models, Descriptions and Specifications
Table 56. BOC Sciences Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 57. BOC Sciences Sales Value Proportion by Product in 2024
Table 58. BOC Sciences Sales Value Proportion by Application in 2024
Table 59. BOC Sciences Sales Value Proportion by Geographic Area in 2024
Table 60. BOC Sciences Reagent Grade Firocoxib SWOT Analysis
Table 61. BOC Sciences Recent Developments
Table 62. TargetMol Corporation Information
Table 63. TargetMol Description and Major Businesses
Table 64. TargetMol Product Models, Descriptions and Specifications
Table 65. TargetMol Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 66. TargetMol Sales Value Proportion by Product in 2024
Table 67. TargetMol Sales Value Proportion by Application in 2024
Table 68. TargetMol Sales Value Proportion by Geographic Area in 2024
Table 69. TargetMol Reagent Grade Firocoxib SWOT Analysis
Table 70. TargetMol Recent Developments
Table 71. Merck KgaA Corporation Information
Table 72. Merck KgaA Description and Major Businesses
Table 73. Merck KgaA Product Models, Descriptions and Specifications
Table 74. Merck KgaA Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Merck KgaA Sales Value Proportion by Product in 2024
Table 76. Merck KgaA Sales Value Proportion by Application in 2024
Table 77. Merck KgaA Sales Value Proportion by Geographic Area in 2024
Table 78. Merck KgaA Reagent Grade Firocoxib SWOT Analysis
Table 79. Merck KgaA Recent Developments
Table 80. Santa Cruz Biotechnology Corporation Information
Table 81. Santa Cruz Biotechnology Description and Major Businesses
Table 82. Santa Cruz Biotechnology Product Models, Descriptions and Specifications
Table 83. Santa Cruz Biotechnology Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 84. Santa Cruz Biotechnology Sales Value Proportion by Product in 2024
Table 85. Santa Cruz Biotechnology Sales Value Proportion by Application in 2024
Table 86. Santa Cruz Biotechnology Sales Value Proportion by Geographic Area in 2024
Table 87. Santa Cruz Biotechnology Reagent Grade Firocoxib SWOT Analysis
Table 88. Santa Cruz Biotechnology Recent Developments
Table 89. Toronto Research Chemicals Corporation Information
Table 90. Toronto Research Chemicals Description and Major Businesses
Table 91. Toronto Research Chemicals Product Models, Descriptions and Specifications
Table 92. Toronto Research Chemicals Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. Toronto Research Chemicals Sales Value Proportion by Product in 2024
Table 94. Toronto Research Chemicals Sales Value Proportion by Application in 2024
Table 95. Toronto Research Chemicals Sales Value Proportion by Geographic Area in 2024
Table 96. Toronto Research Chemicals Reagent Grade Firocoxib SWOT Analysis
Table 97. Toronto Research Chemicals Recent Developments
Table 98. Ambinter Corporation Information
Table 99. Ambinter Description and Major Businesses
Table 100. Ambinter Product Models, Descriptions and Specifications
Table 101. Ambinter Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 102. Ambinter Recent Developments
Table 103. Carbosynth Corporation Information
Table 104. Carbosynth Description and Major Businesses
Table 105. Carbosynth Product Models, Descriptions and Specifications
Table 106. Carbosynth Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 107. Carbosynth Recent Developments
Table 108. Henan Tianfu Chemical Corporation Information
Table 109. Henan Tianfu Chemical Description and Major Businesses
Table 110. Henan Tianfu Chemical Product Models, Descriptions and Specifications
Table 111. Henan Tianfu Chemical Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 112. Henan Tianfu Chemical Recent Developments
Table 113. J&K Scientific Corporation Information
Table 114. J&K Scientific Description and Major Businesses
Table 115. J&K Scientific Product Models, Descriptions and Specifications
Table 116. J&K Scientific Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 117. J&K Scientific Recent Developments
Table 118. Chemsky International Corporation Information
Table 119. Chemsky International Description and Major Businesses
Table 120. Chemsky International Product Models, Descriptions and Specifications
Table 121. Chemsky International Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 122. Chemsky International Recent Developments
Table 123. Chemwill Asia Corporation Information
Table 124. Chemwill Asia Description and Major Businesses
Table 125. Chemwill Asia Product Models, Descriptions and Specifications
Table 126. Chemwill Asia Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 127. Chemwill Asia Recent Developments
Table 128. ChemeGen Corporation Information
Table 129. ChemeGen Description and Major Businesses
Table 130. ChemeGen Product Models, Descriptions and Specifications
Table 131. ChemeGen Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 132. ChemeGen Recent Developments
Table 133. Key Raw Materials Distribution
Table 134. Raw Materials Key Suppliers
Table 135. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 136. Milestones in Production Technology Evolution
Table 137. Distributors List
Table 138. Market Trends and Market Evolution
Table 139. Market Drivers and Opportunities
Table 140. Market Challenges, Risks, and Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Reagent Grade Firocoxib Product Picture
Figure 2. Global Reagent Grade Firocoxib Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Primary Reagent Product Picture
Figure 4. Spectrum-Pure Reagent Product Picture
Figure 5. High-Purity Reagent Product Picture
Figure 6. Global Reagent Grade Firocoxib Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Veterinary
Figure 8. Others
Figure 9. Reagent Grade Firocoxib Report Years Considered
Figure 10. Global Reagent Grade Firocoxib Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 12. Global Reagent Grade Firocoxib Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Reagent Grade Firocoxib Revenue Market Share by Region (2020-2031)
Figure 14. Global Reagent Grade Firocoxib Sales (2020-2031) & (Kg)
Figure 15. Global Reagent Grade Firocoxib Sales (CAGR) by Region (2020-2031) (Kg)
Figure 16. Global Reagent Grade Firocoxib Sales Market Share by Region (2020-2031)
Figure 17. Global Reagent Grade Firocoxib Capacity, Production and Utilization (2020-2031) & (Kg)
Figure 18. Global Reagent Grade Firocoxib Production Trend by Region (2020-2031) (Kg)
Figure 19. Global Reagent Grade Firocoxib Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Reagent Grade Firocoxib Production Growth Rate in North America (2020-2031) & (Kg)
Figure 22. Reagent Grade Firocoxib Production Growth Rate in Europe (2020-2031) & (Kg)
Figure 23. Reagent Grade Firocoxib Production Growth Rate in China (2020-2031) & (Kg)
Figure 24. Reagent Grade Firocoxib Production Growth Rate in Japan (2020-2031) & (Kg)
Figure 25. Top 5 and Top 10 Manufacturers Reagent Grade Firocoxib Sales Volume Market Share in 2024
Figure 26. Global Reagent Grade Firocoxib Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Primary Reagent Revenue Market Share by Manufacturer in 2024
Figure 29. Spectrum-Pure Reagent Revenue Market Share by Manufacturer in 2024
Figure 30. High-Purity Reagent Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Reagent Grade Firocoxib Sales Market Share by Type (2020-2031)
Figure 34. Global Reagent Grade Firocoxib Revenue Market Share by Type (2020-2031)
Figure 35. Global Reagent Grade Firocoxib Sales Market Share by Application (2020-2031)
Figure 36. Global Reagent Grade Firocoxib Revenue Market Share by Application (2020-2031)
Figure 37. North America Reagent Grade Firocoxib Sales YoY (2020-2031) & (Kg)
Figure 38. North America Reagent Grade Firocoxib Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Reagent Grade Firocoxib Sales Revenue (US$ Million) in 2024
Figure 40. North America Reagent Grade Firocoxib Sales Volume (Kg) by Type (2020- 2031)
Figure 41. North America Reagent Grade Firocoxib Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Reagent Grade Firocoxib Sales Volume (Kg) by Application (2020-2031)
Figure 43. North America Reagent Grade Firocoxib Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Reagent Grade Firocoxib Sales YoY (2020-2031) & (Kg)
Figure 48. Europe Reagent Grade Firocoxib Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Reagent Grade Firocoxib Sales Revenue (US$ Million) in 2024
Figure 50. Europe Reagent Grade Firocoxib Sales Volume (Kg) by Type (2020-2031)
Figure 51. Europe Reagent Grade Firocoxib Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Reagent Grade Firocoxib Sales Volume (Kg) by Application (2020-2031)
Figure 53. Europe Reagent Grade Firocoxib Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 55. France Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Reagent Grade Firocoxib Sales YoY (2020-2031) & (Kg)
Figure 60. Asia-Pacific Reagent Grade Firocoxib Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Reagent Grade Firocoxib Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Reagent Grade Firocoxib Sales Volume (Kg) by Type (2020- 2031)
Figure 63. Asia-Pacific Reagent Grade Firocoxib Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Reagent Grade Firocoxib Sales Volume (Kg) by Application (2020-2031)
Figure 65. Asia-Pacific Reagent Grade Firocoxib Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 70. India Reagent Grade Firocoxib Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Reagent Grade Firocoxib Sales YoY (2020-2031) & (Kg)
Figure 72. Central and South America Reagent Grade Firocoxib Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Reagent Grade Firocoxib Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Reagent Grade Firocoxib Sales Volume (Kg) by Type (2021-2031)
Figure 75. Central and South America Reagent Grade Firocoxib Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Reagent Grade Firocoxib Sales Volume (Kg) by Application (2020-2031)
Figure 77. Central and South America Reagent Grade Firocoxib Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Reagent Grade Firocoxib Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Reagent Grade Firocoxib Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Reagent Grade Firocoxib Sales YoY (2020-2031) & (Kg)
Figure 81. Middle East and Africa Reagent Grade Firocoxib Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Reagent Grade Firocoxib Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Reagent Grade Firocoxib Sales Volume (Kg) by Type (2021-2031)
Figure 84. South America Reagent Grade Firocoxib Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Reagent Grade Firocoxib Sales Volume (Kg) by Application (2020-2031)
Figure 86. Middle East and Africa Reagent Grade Firocoxib Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Reagent Grade Firocoxib Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Reagent Grade Firocoxib Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Reagent Grade Firocoxib Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Reagent Grade Firocoxib Revenue (2020-2025) & (US$ Million)
Figure 91. Reagent Grade Firocoxib Industry Chain Mapping
Figure 92. Regional Reagent Grade Firocoxib Manufacturing Base Distribution (%)
Figure 93. Reagent Grade Firocoxib Production Process
Figure 94. Regional Reagent Grade Firocoxib Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Reagent Grade Firocoxib market?
The top companies in the global Reagent Grade Firocoxib market are BOC Sciences、TargetMol、Merck KgaA.
Related Reports
Reagent Grade Firocoxib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Reagent Grade Firocoxib was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 140
USD 3950.00
(Single User License)
Global Reagent Grade Firocoxib Market Research Report 2026
The global Reagent Grade Firocoxib market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 139
USD 2900.00
(Single User License)
Global Reagent Grade Firocoxib Market Research Report 2025
The global market for Reagent Grade Firocoxib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 104
USD 2900.00
(Single User License)
Reagent Grade Firocoxib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Reagent Grade Firocoxib was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 113
USD 3950.00
(Single User License)
Global Reagent Grade Firocoxib Market Insights, Forecast to 2030
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published Date: 2024-04-15
Pages: 107
USD 4900.00
(Single User License)
Reagent Grade Firocoxib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published Date: 2024-02-23
Pages: 127
USD 3950.00
(Single User License)
Global Reagent Grade Firocoxib Market Research Report 2024
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published Date: 2024-01-09
Pages: 100
USD 2900.00
(Single User License)
Reagent Grade Firocoxib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Reagent Grade Firocoxib was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 140
USD 3950.00 (Single User License)Global Reagent Grade Firocoxib Market Research Report 2026
The global Reagent Grade Firocoxib market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 139
USD 2900.00 (Single User License)Global Reagent Grade Firocoxib Market Research Report 2025
The global market for Reagent Grade Firocoxib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 104
USD 2900.00 (Single User License)Reagent Grade Firocoxib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Reagent Grade Firocoxib was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 113
USD 3950.00 (Single User License)Global Reagent Grade Firocoxib Market Insights, Forecast to 2030
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published: 2024-04-15
Pages: 107
USD 4900.00 (Single User License)Reagent Grade Firocoxib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published: 2024-02-23
Pages: 127
USD 3950.00 (Single User License)Global Reagent Grade Firocoxib Market Research Report 2024
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published: 2024-01-09
Pages: 100
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now